Active, Not Recruiting
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
NCT02673333
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- University of Michigan (Data or Specimen Analysis Only) Ann Arbor, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States